feed,title,long_url,short_url
Barron's,AstraZeneca Sees Higher 2022 Sales. The Stock Is Rising.,https://www.barrons.com/articles/astrazeneca-sees-higher-2022-sales-covid-revenues-set-to-decline-51644488883?mod=RTA,https://bit.ly/3sOGnP5
